If complement inhibition is not applied within 4–5 relapses after MCPggaac haplotype onset, with/without adjacent mutations (CHF, CD46, C3), proteinuria, renal damage, and eventually chronic renal failure will occur. The gene discussed is C3; the disease is chronic kidney disease.